The second half of Alan Jackson’s farewell tour resumes next week. The country music legend will perform on Saturday, Jan. 18 ...

A woman in Georgia has filed a police report after an online scammer claiming to be Alan Jackson swindled her out of nearly ...

The US Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to NMD Pharma’s oral lead development ...

The Grammy-winning musician went public about living — and performing — with a neurological condition called Charcot-Marie-Tooth disease in 2021, about a decade after being diagnosed.

Actio Biosciences, a biotechnology company leveraging a novel platform approach to genetics and precision medicine to develop ...

NMD Pharma Announces FDA Orphan Drug Designation Granted to NMD670 for the Treatment of Patients with Charcot-Marie-Tooth Disease This is the 2nd ...

“I’m tired of broken promises.” Jameson has a genetic disorder called CMT, Charcot-Marie-Tooth disease, that’s largely confining him to a wheelchair. His family has been fighting for City ...

CKD-510 is under development for the treatment of Charcot-Marie-Tooth disease and atrial fibrillation. It is administered through oral route.The drug candidate is a new chemical entity targeting ...

Icerguastat is under clinical development by InFlectis BioScience and currently in Phase I for Charcot-Marie-Tooth Disease Type I B.

Country music legend Alan Jackson is returning to the road for one final tour -- “Last Call: One More for the Road” -- he announced Thursday. Jackson, 65, will continue his tour, which took ...

US FDA grants orphan drug designation to NMD Pharma’s NMD670 to treat patients with Charcot-Marie-tooth disease: Aarhus, Denmark Tuesday, January 7, 2025, 16:00 Hrs [IST] NMD Ph ...